Hansen Ree, A. et al. 2022. Cost-effectiveness of molecularly matched off-label therapies for end-stage cancer – the MetAction precision medicine study. Acta Oncologica. 61, 8 (Aug. 2022), 955–962. DOI:https://doi.org/10.1080/0284186X.2022.2098053.